NS-065/NCNP-01

· NS Pharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NS-065/NCNP-01, covering 2021-07-12 to 2022-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) [Phase 2]